Valneva SE (EPA:VLA)
4.570
-0.128 (-2.72%)
Mar 6, 2026, 4:00 PM CET
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
€252,331
Profits / Employee
€143,282
Market Cap
816.29M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MedinCell | 145 |
| Inventiva | 84 |
| DBV Technologies | 117 |
| Genfit | 188 |
| Nanobiotix | 103 |
| Transgene | 147 |
| Cellectis | 222 |
| Innate Pharma | 174 |
Valneva SE News
- 3 days ago - Valneva to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 15 days ago - Valneva sees lower 2026 sales as third-party revenue winds down - Seeking Alpha
- 15 days ago - Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook - Wallstreet:Online
- 15 days ago - Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook - GlobeNewsWire
- 20 days ago - Valneva Provides Update on Recommendations for Use of IXCHIQ in the United Kingdom - Wallstreet:Online
- 20 days ago - Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom - GlobeNewsWire
- 4 weeks ago - VALNEVA Declaration of shares and voting rights: January 31, 2026 - GlobeNewsWire
- 4 weeks ago - Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ - Wallstreet:Online